| Financial Year |
March 31 2023 |
| Monetary Funds |
2,020,255,201.32 |
| Held-for-trading Financial Assets |
1,230,793.83 |
| Notes Receivable |
462,750,511.76 |
| Accounts Receivable |
2,015,353,771.60 |
| Advances to Suppliers |
974,701,158.57 |
| Other Receivables |
107,505,336.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,954,644,989.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
37,897,300.98 |
| Other Current Assets |
98,861,180.37 |
| Total Current Assets |
8,871,760,709.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
25,881,193.72 |
| Investment Properties |
22,099,919.86 |
| Fixed Assetes |
2,522,766,459.22 |
| Under-construction Projects |
518,913,969.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
795,126,100.31 |
| R&D expenses |
2,035,433.96 |
| Goodwill |
340,132,922.76 |
| Long-Term Deferred and Prepaid Expenses |
11,028,467.91 |
| Deferred Income Tax Assets |
65,298,237.62 |
| Other Non-Current Assets |
78,855,387.65 |
| Sub-Total of Non-Current Assets |
4,424,331,222.23 |
| Total Assets |
13,296,091,931.45 |
| Short-Term Loans |
1,143,918,209.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,629,130,015.48 |
| Accounts Payable |
824,973,570.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,952,248.60 |
| Taxes Payable |
49,654,814.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,329,688.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
565,776,125.16 |
| Other Current Liabilities |
140,387,185.69 |
| Sub-Total of Current Liabilities |
5,602,134,594.02 |
| Long-term Loans |
1,453,299,743.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
117,704,273.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,665,078,215.50 |
| Total Liabilities |
7,267,212,809.52 |
| Paid-In Capital(Or Share Stock) |
271,250,000.00 |
| Capital Surplus |
765,742,938.70 |
| Surplus Reserve |
135,625,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,001,340,494.03 |
| Minority Stockholder's Interest |
1,853,495,815.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,175,383,305.97 |
| Owner's Equity（Stockholder's Equity） |
6,028,879,121.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,296,091,931.45 |
